Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, NeuroOne Medical Technologies Corp maintains a gross margin of 54.20%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -59.02%, while the net margin is -49.71%. These profitability ratios, combined with a Return on Equity (ROE) of -146.27%, provide a clear picture of how effectively NMTC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NMTC competes directly with industry leaders such as POCI and RMTI. With a market capitalization of $40.93M, it holds a leading position in the sector. When comparing efficiency, NMTC's gross margin of 54.20% stands against POCI's 2.78% and RMTI's 17.40%. Such benchmarking helps identify whether NeuroOne Medical Technologies Corp is trading at a premium or discount relative to its financial performance.
